1081 Burrard Street
Daphne Ling, PhD
Postdoctoral Fellow, CHÉOS and Collaboration for Outcomes Research and Evaluation, Faculty of Pharmaceutical Sciences, UBC
Abstract: Management of any disease relies on diagnosis as the crucial first step. For over a century, diagnosis of latent tuberculosis (TB) has relied on the tuberculin skin test, which has several limitations. Most studies evaluating newer tests have only reported on their accuracy, which is insufficient for policy recommendations and guideline development.
This talk will discuss evaluating the added value of new tests or biomarkers using a probabilistic and more holistic framework. Topics will include the use of: 1) multivariable prediction models for risk stratification 2) pragmatic studies to assess clinical utility in routine practice and 3) propensity scores within a diagnostic and health systems context.
This talk is open and will include a light lunch.